Compliance is a huge US business with pharma companies baying at the moon for it as a raison D’être of digital health. AdhereTech is working with Cincinnati Children’s Hospital, Weill Cornell Medical Center, and Walter Reed Army Medical Center on clinical trials. AdhereTech’s studies now indicate that users get about a 20 percent lift in adherence versus a standard bottle, and 80 percent of patients given the option of using AdhereTech or a normal bottle opted into the smart bottle. Like Medisafe [TTA 30 Oct], their market is millions who have one or more chronic diseases, but they sub-target those who take more and more expensive medications which can justify this pill dispenser’s cost. Mobihealthnews, FT interview with team early last month
Most Recent Comments